Nu Skin Enterprises (NUS)
(Delayed Data from NYSE)
$8.35 USD
-0.30 (-3.47%)
Updated Sep 4, 2024 04:00 PM ET
After-Market: $8.35 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.35 USD
-0.30 (-3.47%)
Updated Sep 4, 2024 04:00 PM ET
After-Market: $8.35 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
Zacks News
Can Nu Skin (NUS) Spring a Surprise This Earnings Season?
by Zacks Equity Research
Nu Skin (NUS) is all set to report first-quarter 2017 results on May 3, after the closing bell.
Nu Skin Enterprises (NUS) Appoints New Managerial Positions
by Zacks Equity Research
Nu Skin Enterprises Inc. (NUS) has recently appointed Mark H. Lawrence as its new chief financial officer (CFO), who will take position from Mar 27. Lawrence will succeed Ritch Wood, who will now be the company's chief executive officer (CEO), as announced in Dec 2016.
Consumer Staples Stock Earnings on Feb 16: AVP, NUS & ELF
by Zacks Equity Research
Let's take a look at what's in store for the following consumer staples stocks which are likely to release their fourth-quarter 2016 results on Feb 16.
Nu Skin (NUS) Q4 Earnings: Disappointment in the Cards? (revised)
by Zacks Equity Research
Despite the positives, the company faces several regulatory issues.
Nu Skin (NUS) Q4 Earnings: Disappointment in the Cards?
by Zacks Equity Research
Nu-Skin Enterprises, Inc. (NUS) is set to report fourth-quarter 2016 results on Feb 13, after the market closes. The question lingering in investors' minds is, whether the company will be able to deliver a positive earnings surprise in the to-be-reported quarter.
Can Nu Skin Be a Solid Choice for Value Investors?
by Zacks Equity Research
Let's see if company Nu Skin Enterprises Inc. (NUS) stock is a good choice for value-oriented investors right now from multiple angles
Nu Skin (NUS) Provides Weak 2016 Sales View; CEO to Exit
by Zacks Equity Research
Nu Skin Enterprises Inc. (NUS) recently updated its financial guidance for 2016, wherein it expects sluggish sales growth and also announced the exit of its Chief Executive Officer ("CEO"). Shares of Nu Skin declined 7.2% yesterday after the news. The company also provided an initial guidance for 2017.
New Strong Buy Stocks for September 26th
by Indradip Ghosh
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Monday
New Strong Buy Stocks for September 1st
by Indradip Ghosh
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
New Strong Buy Stocks for August 19th
by Indradip Ghosh
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Bear of the Day: Nu Skin (NUS)
by Kevin Cook
Earnings estimates continue to peel away for this network marketer
Bear of the Day: Nu Skin (NUS)
by Kevin Cook
The persistent earnings evaporation here was caught perfectly all year by the Zacks Rank